[1] D. Hasiakos, K. Papakonstantinou, E. Karvouni, and S. Fotiou, “Recurrence of granulosa cell tumor 25 years after initial diagnosis,” Report of a case and review of the literature, European Journal Gynaecolology Oncology, Vol. 29, No. 1, pp. 86–88, 2008.
[2] Rosai and Ackerman’s surgical pathology, 9th edition, Mosby Ed., Edinburgh, pp. 1691–1694, 2004.
[3] P. B. Clement and R. H. Young, “Atlas of Gynecologic Surgical Pathology, 2nd edition,” Saunders Elsevier Ed., New York, USA, pp. 386–391, 2008.
[4] S. Leibl, K. Bodo, M. Gogg-Kammerer, and M Ovarian, “granulosa cell tumors frequently express EGFR (Her-1), Her-3, and Her-4: An immunohistochemical study,” Gynecol Oncol, Vol. 101, No. 1, pp. 18–23, 2006.
[5] Y. K. Lee, N. H. Park, J. W. Kim, Y. S. Song, S. B. Kang, and H. P. Lee, “Characteristic of recurrence in adult-type granulosa cell tumor,” International Journal of Ginecological Cancer, Vol. 18, No. 4, pp. 642–647, 2008.
[6] J. Brown, A. K. Sood, M. T. Deavers, L. Milojevic, and D. M. Gershenson, “Patterns of metastasis in sex cordstromal tumors of the ovary: Can routine staging lymphadenectomy be omitted?” Gynecologic Oncology, Vol. 113, No. 1, pp. 86–90, 2009.
[7] D. M. Gershenson, “Management of early ovarian cancer: Germ cell and sex cord-stromal tumors,” Gynecologic Oncology, Vol. 55, (3 Pt 2), pp. S62–72, 1994.
[8] O. Ismi, Y. Vayisoglu, T. Karabacak, and M. Unal, “Supraclavicular metastases from a sex cord stromal tumor of the ovary,” Tumori, Vol. 95, No. 2, pp. 254–257, 2009.
[9] A. Chauhan, P. Dahiya, H. Singh, M. Gill, and S. Verma, “Isolated breast metastasis from granulosa cell tumor of the ovary,” Arch Gynecol Obstet, Vol. 280, No. 6, pp. 997–999, December 2009.
[10] N. Colombo, G. Parma, V. Zanagnolo, and A. Insinga, “Management of ovarian stromal cell tumors,” Journal of Clinical Oncology, Vol. 25, No. 20, pp. 2944–2951, 2007.
[11] A. Auranen, J. Sundstr?m, J. Ij?s, and S. Grènman, “Prognostic factors of ovarian granulosa cell tumor: A study of 35 patients and review of the literature,” International Journal of Gynecological Cancer, Vol. 17, No. 5, pp. 1011–1018, 2007.
[12] S. E. Rha, S. N. Oh, S. E. Jung, Y. J. Lee, A. W. Lee, Byun, and J. Y. Recurrent, “Ovarian granulosa cell tumors: Clinical and imaging features,” Abdom Imaging, Vol. 33, No. 1, pp. 119–125, 2008.
[13] X. Tao, A. K. Sood, M. T. Deavers, K. M. Schmeler, A. M. Nick, R. L. Coleman, L. Milojevic, D. M. Gershenson, and J. Brown, “Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors,” Gynecology Oncology, Vol. 114, No. 3, pp. 431–436, September 2009.
[14] M. A. Farinola, A. M. Gown, and K. Judson, “Estrogen receptor alpha in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors,” International Journal of Gynecological Pathology, Vol. 26, No. 4, pp. 375–382, 2007.
[15] G. H?lscher, C. Anthuber, G. Bastert, A. Burges, D. Mayr, E. Oberlechner, G. Schubert-Fritschle, S. Sinz, H. Sommer, B. Schmalfeldt, and J. Engel, “Malignant Ovarian Tumors' of the Munich Cancer Center. Improvement of survival in sex cord stromal tumors—an observational study with more than 25 years follow-up,” Acta Obstetricia et Gynecologica Scandinavica, Vol. 88, No. 4, pp. 440–448, 2009.
[16] G. V. Koukourakis, V. E. Kouloulias, M. J. Koukourakis, G. A. Zacharias, C. Papadimitriou, K. Mystakidou, K. Pistevou-Gompaki, J. Kouvaris, and A. Gouliamos, “Granulosa cell tumor of the ovary: Tumor review,” Integrative Cancer Therapies, Vol. 7, No. 3, pp. 204–215, 2008.